Exhibit
23.1
Consent of Independent Registered Public Accounting
Firm
Monopar
Therapeutics Inc.
We
hereby consent to the use in this Registration Statement on Form
S-1 of our report dated February 26, 2019, relating to the
financial statements of Monopar Therapeutics Inc., which appear in
such Registration Statement.
We also
consent to the reference to us under the caption
“Experts” in this Registration Statement.
/s/ BPM
LLP
San
Francisco, California
August
15, 2019